Weighted Average Number of Shares Outstanding, Basic of Vistagen Therapeutics, Inc. from 30 Jun 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Vistagen Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2012 to 31 Dec 2025.
  • Vistagen Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 42,234,405, a 38% increase year-over-year.
  • Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 30,877,029, a 60% increase from 2023.
  • Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 19,354,500, a 178% increase from 2022.
  • Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 6,958,749, a 5.4% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Vistagen Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 42,234,405 +11,522,533 +38% 01 Oct 2025 31 Dec 2025 10-Q 12 Feb 2026 2026 Q3
Q3 2025 35,749,160 +5,116,813 +17% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2026 Q2
Q2 2025 31,930,665 +1,327,230 +4.3% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2026 Q1
Q1 2025 30,877,029 +11,522,529 +60% 01 Jan 2025 31 Mar 2025 10-K 17 Jun 2025 2025 FY
Q4 2024 30,711,872 +1,323,787 +4.5% 01 Oct 2024 31 Dec 2024 10-Q 12 Feb 2026 2026 Q3
Q3 2024 30,632,347 +20,589,817 +205% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2026 Q2
Q2 2024 30,603,435 +23,266,430 +317% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2026 Q1
Q1 2024 19,354,500 +12,190,701 +170% 01 Jan 2024 31 Mar 2024 10-K 17 Jun 2025 2025 FY
Q4 2023 29,388,085 +22,493,482 +326% 01 Oct 2023 31 Dec 2023 10-Q 13 Feb 2025 2025 Q3
Q3 2023 10,042,530 +3,148,822 +46% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2025 Q2
Q2 2023 7,337,005 +450,269 +6.5% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2025 Q1
Q1 2023 7,163,799 +279,396 +4.1% 01 Jan 2023 31 Mar 2023 10-K 28 Jun 2023 2023 FY
Q4 2022 6,894,603 +150,314 +2.2% 01 Oct 2022 31 Dec 2022 10-Q 13 Feb 2024 2024 Q3
Q3 2022 6,893,708 +452,780 +7% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2024 Q2
Q2 2022 6,886,736 +555,931 +8.8% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2024 Q1
Q1 2022 6,884,403 01 Jan 2022 31 Mar 2022 10-K 28 Jun 2023 2023 FY
Q4 2021 6,744,289 01 Oct 2021 31 Dec 2021 10-K 28 Jun 2023 2023 FY
Q3 2021 6,440,928 01 Jul 2021 30 Sep 2021 10-K 28 Jun 2023 2023 FY
Q2 2021 6,330,805 01 Apr 2021 30 Jun 2021 10-K 28 Jun 2023 2023 FY
Q4 2015 1,765,641 +463,325 +36% 01 Oct 2015 31 Dec 2015 10-Q 16 Feb 2016 2016 Q3
Q3 2015 1,624,371 +345,104 +27% 01 Jul 2015 30 Sep 2015 10-Q 16 Nov 2015 2016 Q2
Q1 2015 1,466,402 +367,660 +33% 01 Jan 2015 31 Mar 2015 10-K 24 Jun 2016 2016 FY
Q4 2014 1,302,316 +191,787 +17% 01 Oct 2014 31 Dec 2014 10-K 24 Jun 2016 2016 FY
Q3 2014 1,279,267 +197,738 +18% 01 Jul 2014 30 Sep 2014 10-K 24 Jun 2016 2016 FY
Q2 2014 1,229,504 -19,610,437 -94% 01 Apr 2014 30 Jun 2014 10-K 24 Jun 2016 2016 FY
Q1 2014 1,098,742 01 Jan 2014 31 Mar 2014 10-K 29 Jun 2015 2015 FY
Q4 2013 1,110,529 -17,181,772 -94% 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015 2015 Q3
Q3 2013 1,081,529 01 Jul 2013 30 Sep 2013 10-Q 19 Nov 2014 2014 Q2
Q2 2013 20,839,941 +3,997,286 +24% 01 Apr 2013 30 Jun 2013 10-Q 12 Aug 2014 2014 Q1
Q4 2012 18,292,301 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014 2013 Q3
Q2 2012 16,842,655 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013 2013 Q1

Vistagen Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 30,877,029 +11,522,529 +60% 01 Apr 2024 31 Mar 2025 10-K 17 Jun 2025 2025 FY
2023 19,354,500 +12,395,751 +178% 01 Apr 2023 31 Mar 2024 10-K 17 Jun 2025 2025 FY
2022 6,958,749 +359,462 +5.4% 01 Apr 2022 31 Mar 2023 10-K 11 Jun 2024 2024 FY
2021 6,599,287 -79,534,357 -92% 01 Apr 2021 31 Mar 2022 10-K 28 Jun 2023 2023 FY
2020 86,133,644 01 Apr 2020 31 Mar 2021 10-K 23 Jun 2022 2022 FY
2015 1,767,957 +449,144 +34% 01 Apr 2015 31 Mar 2016 10-K 24 Jun 2016 2016 FY
2014 1,318,813 +220,071 +20% 01 Apr 2014 31 Mar 2015 10-K 24 Jun 2016 2016 FY
2013 1,098,742 -19,741,199 -95% 01 Apr 2013 31 Mar 2014 10-K 29 Jun 2015 2015 FY
2012 20,839,941 01 Apr 2012 31 Mar 2013 10-Q 12 Aug 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.